nimodipine has been researched along with Vascular Diseases in 5 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vascular dementia is second most common cause of dementia." | 2.43 | [Pharmacological treatment of vascular cognitive impairment]. ( Bidzan, L, 2006) |
| "Ocular ischaemic syndrome is a progressive and serious vision-threatening condition that is usually associated with carotid artery disease, and poor effective therapeutic options are available." | 1.42 | Reversed ocular ischaemic syndrome secondary to carotid cavernous sinus embolisation. ( Branco, G; Costa, JM; Isidro, F; Reizinho, C, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, S | 1 |
| Zivadinov, R | 1 |
| Ramasamy, D | 1 |
| Ambrus, JL | 1 |
| Isidro, F | 1 |
| Reizinho, C | 1 |
| Branco, G | 1 |
| Costa, JM | 1 |
| Ducros, A | 1 |
| Bousser, MG | 1 |
| Bidzan, L | 1 |
| Volpin, L | 1 |
| Curri, D | 1 |
| Zanusso, M | 1 |
| Cervellini, P | 1 |
| Benedetti, A | 1 |
3 reviews available for nimodipine and Vascular Diseases
| Article | Year |
|---|---|
Reversible cerebral vasoconstriction syndrome (RCVS) in antiphospholipid antibody syndrome (APLA): the role of centrally acting vasodilators. Case series and review of literature.
Topics: Adult; Aged; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Brain; Calcium Channel Blockers | 2014 |
Reversible cerebral vasoconstriction syndrome.
Topics: Age of Onset; Cerebral Angiography; Female; Humans; Male; Nimodipine; Sex Factors; Stroke; Subarachn | 2009 |
[Pharmacological treatment of vascular cognitive impairment].
Topics: Animals; Cerebrovascular Disorders; Cognition Disorders; Dementia, Multi-Infarct; Dementia, Vascular | 2006 |
2 other studies available for nimodipine and Vascular Diseases
| Article | Year |
|---|---|
Reversed ocular ischaemic syndrome secondary to carotid cavernous sinus embolisation.
Topics: Aged; Carotid Arteries; Carotid-Cavernous Sinus Fistula; Cavernous Sinus; Embolization, Therapeutic; | 2015 |
Post-SAH vasospasm in patients treated with oral nimodipine.
Topics: Administration, Oral; Aneurysm; Humans; Nimodipine; Vascular Diseases | 1987 |